Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Velcade
Pharma
With GSK's 2nd Blenrep win, analysts see blockbuster comeback
Blenrep isn't included in GSK's £38 billion sales outlook for 2031, but two groups of analysts are projecting blockbuster-level sales for the drug.
Angus Liu
Mar 7, 2024 10:14am
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Dec 12, 2023 12:00pm
Sanofi targets first-line myeloma as Sarclisa delivers trial win
Dec 7, 2023 11:26am
After pulling Blenrep, GSK touts combo trial in multiple myeloma
Nov 27, 2023 10:36am
Takeda, Merck-Kelun, Astellas—Fierce Pharma Asia
Jul 29, 2022 11:08am
Velcade sales halved at Takeda amid multiple US generic entries
Jul 28, 2022 11:34am
